Leukemia, lymphoma squarely in sights of new class of drugs

(University of Texas Health Science Center at San Antonio) A new class of drugs degrades an essential survival protein in cancer cells while sparing platelets. Therefore, it could be a safer therapy for multiple types of leukemia and lymphoma, say researchers at UT Health San Antonio.